Advertisement

Topics

Arrowroot Capital Leads $16.5 Million Investment In MedNet Solutions

09:36 EST 1 Dec 2016 | PR Newswire

MINNETONKA, Minn., Dec. 1, 2016 /PRNewswire/ -- MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is pleased to announce that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has led a new $16.5 million growth investment in MedNet Solutions. Arrowroot partnered with past investors along with new entrant Cohesive Capital Partners – a private equity firm that makes direct investments exclusively alongside high quality private equity sponsors – on this second round of financing.  This significant new investment will fuel the continued growth and success of MedNet Solutions and iMedNet, the company's comprehensive eClinical technology platform. iMedNet stands apart from other eClinical solutions due to its superior flexibility, affordability and ease-of-use.

"We are excited to continue to partner with MedNet's leadership team during this inflection point in the company's growth," stated Matthew Safaii, Managing Partner of Arrowroot Capital. "With the adoption of the iMedNet SaaS product across multiple verticals and within both CROs and enterprises, the company continues to be the trusted leader in its segment."

"We have found the MedNet management team to be extremely impressive and believe they will continue to accelerate the company's growth through its differentiated iMedNet offering," said John Barber, Managing Partner of Cohesive Capital Partners. "Additionally, we are excited to be partnering with Arrowroot Capital, whose team has proven themselves to be leaders in the SaaS investment space."

"This is an incredibly exciting time for MedNet," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "2016 will be another banner year in terms of iMedNet product enhancements, new iMedNet installations and overall corporate growth. This new funding from our valued investment partners comes at an ideal time – allowing us to capitalize on our momentum, accelerate our product development efforts, and expand our world-wide sales and marketing initiatives."

Stay in touch with MedNet:

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions designed for the global life sciences community. MedNet's proven, flexible and easy-to-use cloud-based eClinical systems dramatically improve the efficiency of clinical studies and registries of all types and sizes. Beyond simply electronic data capture (EDC), MedNet's solutions deliver the tools and dashboards required to expertly manage all aspects of clinical research. Since 2001, pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit www.mednetstudy.com.

About Arrowroot Capital

Arrowroot Capital is a software-focused growth equity firm that invests in growing and healthy SaaS-based businesses across all industries. Due to Arrowroot's business model expertise, the firm takes a hands-on approach in assisting portfolio companies reach their growth goals.  Arrowroot typically targets investment opportunities of anywhere between $1 million and $15 million, but has access to larger pools of capital if needed.  For more information, please visit www.arrowrootcapital.com.

MedNet Contact InformationDirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305 
USA
763.258.2735
contact@mednetstudy.com

Arrowroot Contact Information           
Matthew J. Safaii
Managing Partner
Arrowroot Capital
100 Wilshire Blvd, Suite 1830
Santa Monica, CA  90401
USA
310.566.5966
contact@arrowrootcapital.com

Logo - http://photos.prnewswire.com/prnh/20160512/366985LOGO

Logo - http://photos.prnewswire.com/prnh/20161201/444810LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arrowroot-capital-leads-165-million-investment-in-mednet-solutions-300371655.html

SOURCE MedNet Solutions

NEXT ARTICLE

More From BioPortfolio on "Arrowroot Capital Leads $16.5 Million Investment In MedNet Solutions"

Quick Search
Advertisement
 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...